Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Type 1 Diabetes Treated With Leptin
Open Access
- 24 June 2022
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 71 (9) , 1902-1914
Abstract
Leptin, a hormone secreted by adipocytes, exhibits therapeutic potential for the treatment of type 1 diabetes (T1D). Protein tyrosine phosphatase 1B (PTP1B) is a key enzyme that negatively regulates leptin receptor signaling. Here, the role of PTP1B in the treatment of T1D was investigated using PTP1B-deficient (knockout [KO]) mice and a PTP1B inhibitor. T1D wild-type (WT) mice induced by streptozotocin showed marked hyperglycemia compared with non-T1D WT mice. KO mice displayed significantly improved glucose metabolism equivalent to non-T1D WT mice, whereas peripheral or central administration of leptin partially improved glucose metabolism in T1D WT mice. Peripheral combination therapy of leptin and a PTP1B inhibitor in T1D WT mice improved glucose metabolism to the same level as non-T1D WT mice. Leptin was shown to act on the arcuate nucleus in the hypothalamus to suppress gluconeogenesis in liver and enhance glucose uptake in both brown adipose tissue and soleus muscle through the sympathetic nervous system. These effects were enhanced by PTP1B deficiency. Thus, treatment of T1D with leptin, PTP1B deficiency, or a PTP1B inhibitor was shown to enhance leptin activity in the hypothalamus to improve glucose metabolism. These findings suggest a potential alternative therapy for T1D.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- Leptin Engages a Hypothalamic Neurocircuitry to Permit Survival in the Absence of InsulinCell Metabolism, 2013
- The Genetics ofPTPN1and Obesity: Insights from Mouse Models of Tissue-Specific PTP1B DeficiencyJournal of Obesity, 2012
- Leptin Therapy Reverses Hyperglycemia in Mice With Streptozotocin-Induced Diabetes, Independent of Hepatic Leptin SignalingDiabetes, 2011
- Leptin Activates a Novel CNS Mechanism for Insulin-Independent Normalization of Severe Diabetic HyperglycemiaEndocrinology, 2010
- Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in miceProceedings of the National Academy of Sciences of the United States of America, 2010
- Leptin therapy in insulin-deficient type I diabetesProceedings of the National Academy of Sciences of the United States of America, 2010
- PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in miceJournal of Clinical Investigation, 2010
- Leptin-Dependent Control of Glucose Balance and Locomotor Activity by POMC NeuronsCell Metabolism, 2009
- Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balanceNature Neuroscience, 2008
- Leptin controls adipose tissue lipogenesis via central, STAT3–independent mechanismsNature Medicine, 2008